American Elements specializes in producing high purity Yttrium Aluminum Oxide sputtering targets with the highest possible density and smallest possible average grain sizes for use in semiconductor, chemical vapor deposition (CVD) and physical vapor deposition (PVD) display and optical applications. Our standard Sputtering Targets for thin film are available monoblock or bonded with dimensions and configurations up to 820 mm with hole drill locations and threading, beveling, grooves and backing designed to work with both older sputtering devises as well as the latest process equipment, such as large area coating for solar energy or fuel cells and flip-chip applications. Research sized targets are also produced as well as custom sizes and alloys. All targets are analyzed using best demonstrated techniques including X-Ray Fluorescence (XRF), Glow Discharge Mass Spectrometry (GDMS), and Inductively Coupled Plasma (ICP). "Sputtering" allows for thin film deposition of an ultra high purity sputtering metallic or oxide material onto another solid substrate by the controlled removal and conversion of the target material into a directed gaseous/plasma phase through ionic bombardment. We can also provide targets outside this range in addition to just about any size rectangular, annular, or oval target. Materials are produced using crystallization, solid state and other ultra high purification processes such as sublimation. American Elements specializes in producing custom compositions for commercial and research applications and for new proprietary technologies. American Elements also casts any of the rare earth metals and most other advanced materials into rod, bar or plate form, as well as other machined shapes and through other processes such as nanoparticles (See also application discussion at Nanotechnology Information and at Quantum Dots) and in the form of solutions and organometallics. Oxide compounds are not conductive to electricity. However, certain perovskite structured oxides are electronically conductive finding application in the cathode of solid oxide fuel cells and oxygen generation systems. Other shapes are available by request.
Yttrium is a Block D, Group 3, Period 5 element. The electronic configuration is [Kr] 4d1 5s2. In its elemental form yttrium's CAS number is 7440-65-5. The yttrium atom has a radius of 177.6.pm and it's Van der Waals radius is 200.pm. Yttrium has the highest thermo-dynamic affinity for oxygen of any element. This characteristic is the basis for many of its applications. While not part of the rare earth series, it resembles the heavy rare earths which are sometimes referred to as the “yttrics” for this reason. Another unique characteristic derives from its ability to form crystals with useful properties. Yttrium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Some of the many applications of yttrium include in ceramics for crucibles for molten reactive metals, in florescent lighting phosphors, computer displays and automotive fuel consumption sensors.Yttria stabilized zirconium oxide are used in high temperature applications, such as in thermal plasma sprays to protect aerospace high temperature surfaces and as an electrolyte in solid oxide fuel cells. Crystals of the yttrium-iron-garnet (YIG) variety are essential to microwave communication equipment. The phosphor Eu:Y2O2S creates the red color in televisions. Crystals of the yttrium-aluminum-garnet (YAG) variety are utilized with neodymium in a number of laser applications. Yttria can also increase the strength of metallic alloys.
Aluminum is a Block P, Group 13, Period 3 element. The electronic configuration is [Ne] 3s2 3p1. In its elemental form aluminum's CAS number is 7429-90-5. The aluminum atom has a radius of 143.2.pm and it's Van der Waals radius is 200.pm. Aluminum is a silvery-white metal that possesses many desirable characteristics. It is light, nonmagnetic and nonsparking.
It stands second among metals in the scale of malleability, and sixth in ductility. It is extensively used in many industrial applications where a strong, light, easily constructed material is needed. Although it's electrical conductivity is only about 60% that of copper, it is used in electrical transmission lines because of its light weight. Pure aluminum is soft and lacks strength, but alloyed with small amounts of copper, magnesium, silicon, manganese, or other elements impart a variety of useful properties. These alloys are of vital importance in the construction of modern aircraft and rockets. Aluminum, evaporated in a vacuum, forms a highly reflective coating for both visible light and radiant heat. They are used to coat telescope mirrors. Aluminum is available as metal and compounds with purities from 99% to 99.9999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. |
| |
Periodic table of the elements science and academic information, elements and advanced materials data, scientific presentations and all pages, designs, concepts, logos, and color schemes herein are the copyrighted proprietary rights and intellectual property of American Elements. American Elements is a U.S. Registered Trademark. © 2001-2009. American Elements. All rights reserved. |
 |
|
Recent Research & Development for Yttrium
- Liver transplantation after radioembolization in a patient with unresectable HCC.
Luna LE, Kwo PY, Roberts LR, Mettler TA, Gansen DN, Andrews JC, Wiseman GA, Misra VL.
Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):679-83.
PMID: 19881519 [PubMed - in process]
- Assessment of Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) laser fiber wear and tear grade during visual laser ablation of prostatic adenoma.
Rózanski W, Klimek L, Jablonowski Z, Sosnowski M.
Photomed Laser Surg. 2009 Oct;27(5):799-805.
PMID: 19878030 [PubMed - in process]
- Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option.
Saxena A, Bester L, Chua TC, Chu FC, Morris DL.
Ann Surg Oncol. 2009 Oct 30. [Epub ahead of print]
PMID: 19876691 [PubMed - as supplied by publisher]
- Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
Fleming CJ, Andrews JC, Wiseman GA, Gansen DN, Roberts LR.
J Vasc Interv Radiol. 2009 Nov;20(11):1460-3.
PMID: 19875064 [PubMed - in process]
- Genotoxic effects of 1064-nm Nd:YAG and 532-nm KTP lasers on fibroblast cell cultures.
Senturk N, Bedir A, Bilgici B, Aydin F, Okuyucu A, Ozmen ZC, Turanli AY.
Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
PMID: 19874333 [PubMed - as supplied by publisher]
- Axillary hair removal with 1064-nm Nd:YAG laser increases sweat production.
Aydin F, Pancar GS, Senturk N, Bek Y, Yuksel EP, Canturk T, Turanli AY.
Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
PMID: 19874331 [PubMed - as supplied by publisher]
- The management of treatment-resistant biliary calculi using percutaneous endourologic techniques.
Ray AA, Davies ET, Duvdevani M, Razvi H, Denstedt JD.
Can J Surg. 2009 Oct;52(5):407-12.
PMID: 19865576 [PubMed - in process]
- [Liver chemoembolization: an update.]
Roche A.
Bull Cancer. 2009 Oct 29. [Epub ahead of print] French.
PMID: 19864205 [PubMed - as supplied by publisher]
- Results of intraocular lens implantation with capsular tension ring in subluxated crystalline or cataractous lenses in children.
Das P, Ram J, Brar GS, Dogra MR.
Indian J Ophthalmol. 2009 Nov-Dec;57(6):431-6.
PMID: 19861744 [PubMed - in process]
- Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma.
Goff L, Summers K, Iqbal S, Kuhlmann J, Kunz M, Louton T, Hagenbeek A, Morschhauser F, Putz B, Lister A, Rohatiner A.
J Clin Oncol. 2009 Oct 26. [Epub ahead of print]
PMID: 19858392 [PubMed - as supplied by publisher]
- Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study.
Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R.
J Vasc Interv Radiol. 2009 Oct 23. [Epub ahead of print]
PMID: 19854068 [PubMed - as supplied by publisher]
- The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases.
Sato KT, Omary RA, Takehana C, Ibrahim S, Lewandowski RJ, Ryu RK, Salem R.
J Vasc Interv Radiol. 2009 Oct 19. [Epub ahead of print]
PMID: 19846320 [PubMed - as supplied by publisher]
- Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver Tumors.
Bilbao JI, Garrastachu P, Herráiz MJ, Rodríguez M, Ińarrairaegui M, Rodríguez J, Hernández C, de la Cuesta AM, Arbizu J, Sangro B.
Cardiovasc Intervent Radiol. 2009 Oct 20. [Epub ahead of print]
PMID: 19841973 [PubMed - as supplied by publisher]
- Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
Gisselbrecht C, Vose J, Nademanee A, Gianni AM, Nagler A.
Oncologist. 2009;14 Suppl 2:41-51.
PMID: 19819923 [PubMed - in process]
- Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
Morschhauser F, Dreyling M, Rohatiner A, Hagemeister F, Bischof Delaloye A.
Oncologist. 2009;14 Suppl 2:17-29.
PMID: 19819921 [PubMed - in process]
- Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
Gregory SA, Hohloch K, Gisselbrecht C, Tobinai K, Dreyling M.
Oncologist. 2009;14 Suppl 2:4-16.
PMID: 19819920 [PubMed - in process]
- Imaging in targeted delivery of therapy to cancer.
Dancey G, Begent RH, Meyer T.
Target Oncol. 2009 Oct 8. [Epub ahead of print]
PMID: 19838639 [PubMed - as supplied by publisher]
- Polymerization of Enantiopure Monomers Using Syndiospecific Catalysts: A New Approach To Sequence Control in Polymer Synthesis.
Kramer JW, Treitler DS, Dunn EW, Castro PM, Roisnel T, Thomas CM, Coates GW.
J Am Chem Soc. 2009 Oct 16. [Epub ahead of print]
PMID: 19835375 [PubMed - as supplied by publisher]
- [Minimally invasive tumor ablation in the liver]
Wybranski C, Mohnike K, Ricke J.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Oct;44(10):670-7; quiz 679. Epub 2009 Oct 15. German.
PMID: 19834832 [PubMed - in process]
- Intraarticular adalimumab in a patient with pigmented villonodular synovitis.
Kobak S.
Rheumatol Int. 2009 Oct 10. [Epub ahead of print]
PMID: 19820943 [PubMed - as supplied by publisher]
|
|